31-45 of 232
Anti-IgE Therapies and the Future of CSU Care
On the Frontlines of Chronic Spontaneous UrticariaAnti-IgE Therapies and the Future of CSU Care
Predicting Which Patients Benefit from Biologics in Severe Asthma
Clinician's RoundtablePredicting Which Patients Benefit from Biologics in Severe Asthma
Can microRNAs Predict Steroid Response in Childhood Asthma?
Clinician's RoundtableCan microRNAs Predict Steroid Response in Childhood Asthma?
New Frontiers in Severe Asthma Management
Clinician's RoundtableNew Frontiers in Severe Asthma Management
Using Biomarkers to Guide Severe Asthma Treatment
Clinician's RoundtableUsing Biomarkers to Guide Severe Asthma Treatment
- advertisement
Modern Approaches to Chronic Spontaneous Urticaria Care
On the Frontlines of Chronic Spontaneous UrticariaModern Approaches to Chronic Spontaneous Urticaria Care
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
NeuroFrontiersSPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
NeuroFrontiersRAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
Recognizing Neuroimmune Drivers of Itch in Atopic Dermatitis and Prurigo Nodularis
DermConsultRecognizing Neuroimmune Drivers of Itch in Atopic Dermatitis and Prurigo Nodularis
Addressing Shingles Risk in Adults Ages 50 to 55
VacciNationAddressing Shingles Risk in Adults Ages 50 to 55
COPD and Cardiovascular Risk: The Expanding Role of Biomarkers
Clinician's RoundtableCOPD and Cardiovascular Risk: The Expanding Role of Biomarkers
- advertisement
Telemedicine and School-Based Asthma Care: Evidence from TEAM-UP
Clinician's RoundtableTelemedicine and School-Based Asthma Care: Evidence from TEAM-UP
Albuterol-Budesonide Rescue for Asthma: MANDALA Safety and Use Patterns
AudioAbstractsAlbuterol-Budesonide Rescue for Asthma: MANDALA Safety and Use Patterns
Gaps in Shingles Vaccination: What Clinicians Need to Know
VacciNationGaps in Shingles Vaccination: What Clinicians Need to Know















































